Dacarbazine is a chemotherapeutic drug for metastatic melanoma [19] and vemurafenib is a B-Raf enzyme inhibitor to treat late stage of melanoma with BRAF V600E mutation [20]. This evidence concerns the gene BRAF and metastatic melanoma.